admin 管理员组文章数量: 1086019
2024年12月29日发(作者:margintop和paddingtop对行内元素都起作用)
Technical Bulletin
CellTiter-Glo
®
Luminescent
Cell Viability Assay
INSTRUCTIONS FOR USE OF PRODUCTS G7570, G7571, G7572 AND
G7573.
I
N
T
E
G
R
A
T
E
D
S
O
L
U
T
I
O
N
S
use me with
GLOMAX
®
INSTRUMENTS
world-class
I
N
T
E
G
R
A
T
E
D
S
O
L
U
T
I
O
N
S
SERVICE
& SUPPORT
PRINTED IN USA.
Revised 12/12Part# TB288
CellTiter-Glo
®
Luminescent
Cell Viability Assay
All technical literature is available on the Internet at: /protocols/
Please visit the web site to verify that you are using the most current version of this
Technical Bulletin. Please contact Promega Technical Services if you have questions on use
ofthissystem.E-mail:********************
1
t Components and .4
ming the CellTiter-Glo
®
5
.5
ol for the Cell .6
ol for Generating an ATP Standard Curve (optional).........................7
ix.............................................................................................................7
A.
B.
C.
D.
Overview of the CellTiter-Glo
®
7
8
11
12
ption
The CellTiter-Glo
®
Luminescent Cell Viability Assay
(a–e)
is a homogeneous
method to determine the number of viable cells in culture based on quantitation
of the ATP present, which signals the presence of metabolically active cells. The
CellTiter-Glo
®
Assay is designed for use with multiwell-plate formats, making
it ideal for automated high-throughput screening (HTS) and cell proliferation
and cytotoxicity assays. The homogeneous assay procedure (Figure 1) involves
adding a single reagent (CellTiter-Glo
®
Reagent) directly to cells cultured in
serum-supplemented medium. Cell washing, removal of medium or multiple
pipetting steps are not required.
The homogeneous “add-mix-measure” format results in cell lysis and generation
of a luminescent signal proportional to the amount of ATP present (Figure 2).
The amount of ATP is directly proportional to the number of cells present in
culture in agreement with previous reports (1). The CellTiter-Glo
®
Assay relies on
the properties of a proprietary thermostable luciferase (Ultra-Glo™ Recombinant
Luciferase), which generates a stable “glow-type” luminescent signal and
improves performance across a wide range of assay conditions. The luciferase
reaction for this assay is shown in Figure 3. The half-life of the luminescent signal
resulting from this reaction is greater than five hours (Figure4). This extended
half-life eliminates the need for reagent injectors and provides flexibility for
continuous or batch-mode processing of multiple plates. The unique
homogeneous format reduces pipetting errors that may be introduced during
the multiple steps required by other ATP-measurement methods.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 1
CellTiter-Glo
®
Substrate
CellTiter-Glo
®
Buffer
CellTiter-Glo
®
Reagent
Mixer
Luminometer
Figure 1. Flow diagram showing preparation and use of CellTiter-Glo
®
Reagent.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Part# TB288
Page 2
Printed in USA.
Revised 12/12
3
1
7
0
M
A
1
2
_
0
A
System Advantages
•
•
•
•
•
•
Homogeneous:“Add-mix-measure” format reduces the number of plate-
handling steps to fewer than that required for similar ATP assays.
Fast:Data can be recorded 10 minutes after adding reagent.
Sensitive:Measures cells at numbers below the detection limits of
standard colorimetric and fluorometric assays.
Flexible:Can be used with various multiwell formats. Data can be
recorded by luminometer or CCD camera or imaging device.
Robust:Luminescent signal is very stable, with a half-life >5 hours,
depending on cell type and culture medium used.
Able to Multiplex:Can be used with reporter gene assays or other
cell-based assays from Promega (2,3).
4.0 × 10
6
R² = 0.999
L
u
m
i
n
e
s
c
e
n
c
e
(
R
L
U
)
3.5 × 10
6
3.0 × 10
6
2.5 × 10
6
2.0 × 10
6
1.5 × 10
6
1.0 × 10
6
0.5 × 10
6
r² = 0.99
50,000
40,000
30,000
20,000
10,000
0
0
r² = 0.99
0
10,000
20,00030,00040,00050,000
60,000
Cells per Well
Figure 2. Cell number correlates with luminescent output.A direct relationship
exists between luminescence measured with the CellTiter-Glo
®
Assay and the number
of cells in culture over three orders of magnitude. Serial twofold dilutions of HEK293
cells were made in a 96-well plate in DMEM with 10% FBS, and assays were
performed as described in Section3.B. Luminescence was recorded 10minutes after
reagent addition using a GloMax
®
-Multi+ Detection System. Values represent the
mean ± S.D. of four replicates for each cell number. The luminescent signal from
50HEK293 cells is greater than three times the background signal from serum-
supplemented medium without cells. There is a linear relationship (r
2
= 0.99)
between the luminescent signal and the number of cells from 0to 50,000 cells per well.
HO
S
N
COOH
+ATP+O
2
N
S
Ultra-Glo™ Recombinant
Luciferase
Mg
2+
O
S
N
N
S
O
0
+AMP+PP
i
+CO
2
+Light
Beetle LuciferinOxyluciferin
Figure 3. The luciferase -oxygenation of luciferin is catalyzed by
luciferase in the presence of Mg
2+
, ATP and molecular oxygen.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 3
3
1
7
1
M
A
1
2
_
0
A
0
R
e
l
a
t
i
v
e
L
u
m
i
n
e
s
c
e
n
c
e
(
%
)
250300
Time (minutes)
Figure 4. Extended luminescent half-life allows high-throughput batch
stability is shown for three common cell lines. HepG2 and BHK-21
cells were grown and assayed in MEM containing 10% FBS, while CHO-K1 cells
were grown and assayed in DME/F-12 containing 10% FBS. CHO-K1, BHK-21 and
HepG2 cells, at 25,000 cells per well, were added to a 96-well plate. After an equal
volume of CellTiter-Glo
®
Reagent was added, plates were shaken and luminescence
monitored over time with the plates held at 22°C. The half-lives of the luminescent
signals for the CHO-K1, BHK-21 and HepG2 cells were approximately 5.4, 5.2 and
5.8hours, respectively.
t Components and Storage Conditions
ProductSizeCat.#
CellTiter-Glo
®
Luminescent Cell Viability Assay10mlG7570
Substrate is sufficient for 100 assays at 100µl/assay in 96-well plates or 400 assays at
25µl/assay in 384-well plates. Includes:
•1 × 10ml
•1 vial
CellTiter-Glo
®
Buffer
CellTiter-Glo
®
Substrate (lyophilized)
ProductSizeCat.#
CellTiter-Glo
®
Luminescent Cell Viability Assay10 × 10mlG7571
Each vial of substrate is sufficient for 100 assays at 100µl/assay in 96-well plates or
400 assays at 25µl/assay in 384-well plates (1,000 to 4,000 total assays). Includes:
•10 × 10ml
•10 vials
CellTiter-Glo
®
Buffer
CellTiter-Glo
®
Substrate (lyophilized)
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Part# TB288
Page 4
Printed in USA.
Revised 12/12
3
1
7
3
M
A
1
2
_
0
A
100
90
80
70
60
50
40
30
20
10
0
CHO-K1
BHK-21
HepG2
ProductSizeCat.#
CellTiter-Glo
®
Luminescent Cell Viability Assay100mlG7572
Substrate is sufficient for 1,000 assays at 100µl/assay in 96-well plates or 4,000
assays at 25µl/assay in 384-well plates. Includes:
•1 × 100ml
•1 vial
CellTiter-Glo
®
Buffer
CellTiter-Glo
®
Substrate (lyophilized)
ProductSizeCat.#
CellTiter-Glo
®
Luminescent Cell Viability Assay10 × 100mlG7573
Each vial of substrate is sufficient for 1,000 assays at 100µl/assay in 96-well plates or
4,000 assays at 25µl/assay in 384-well plates (10,000to 40,000 total assays). Includes:
•10 × 100ml
•10 vials
CellTiter-Glo
®
Buffer
CellTiter-Glo
®
Substrate (lyophilized)
Storage Conditions:For long-term storage, store the lyophilized CellTiter-Glo
®
Substrate and CellTiter-Glo
®
Buffer at –20°C. For frequent use, the CellTiter-Glo
®
Buffer can be stored at 4°C or room temperature for 48hours without loss of
activity. See product label for expiration date information. Reconstituted
CellTiter-Glo
®
Reagent (Buffer plus Substrate) can be stored at room temperature
for up to 8hours with <10% loss of activity, at 4°C for 48hours with ~5% loss
of activity, at 4°C for 4days with ~20% loss of activity or at –20°C for 21weeks
with ~3% loss of activity. The reagent is stable for up to ten freeze-thaw cycles,
with less than 10% loss of activity.
ming the CellTiter-Glo
®
Assay
Materials to Be Supplied by the User
•opaque-walled multiwell plates adequate for cell culture
•multichannel pipette or automated pipetting station for reagent delivery
•device (plate shaker) for mixing multiwell plates
•luminometer, CCD camera or imaging device capable of reading multiwell plates
•optional:ATP for use in generating a standard curve (Section 3.C)
t Preparation
the CellTiter-Glo
®
Buffer, and equilibrate to room temperature prior
to use. For convenience the CellTiter-Glo
®
Buffer may be thawed and
stored at room temperature for up to 48hours prior to use.
brate the lyophilized CellTiter-Glo
®
Substrate to room temperature
prior to use.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 5
t Preparation (continued)
er the appropriate volume (10ml for Cat.# G7570 and G7571, or 100ml
for Cat.# G7572 and G7573) of CellTiter-Glo
®
Buffer into the amber bottle
containing CellTiter-Glo
®
Substrate to reconstitute the lyophilized
enzyme/substrate mixture. This forms the CellTiter-Glo
®
Reagent.
by gently vortexing, swirling or inverting the contents to obtain a
homogeneous solution. The CellTiter-Glo
®
Substrate should go into
solution easily in less than 1minute.
ol for the Cell Viability Assay
We recommend that you perform a titration of your particular cells to
determine the optimal number and ensure that you are working within the
linear range of the CellTiter-Glo
®
Assay. Figure2 provides an example of such
a titration of HEK293 cells using 0 to 50,000 cells per well in a 96-well format.
e opaque-walled multiwell plates with mammalian cells in culture
medium, 100µl per well for 96-well plates or 25µl per well for 384-well
plates.
!
Multiwell plates must be compatible with the luminometer used.
e control wells containing medium without cells to obtain a value for
background luminescence.
the test compound to experimental wells, and incubate according to
culture protocol.
brate the plate and its contents at room temperature for
approximately 30 minutes.
a volume of CellTiter-Glo
®
Reagent equal to the volume of cell culture
medium present in each well (e.g., add 100µl of reagent to 100µl of medium
containing cells for a 96-well plate, or add 25µl of reagent to 25µl of
medium containing cells for a 384-well plate).
contents for 2 minutes on an orbital shaker to induce cell lysis.
the plate to incubate at room temperature for 10 minutes to stabilize
luminescent signal.
Note:Uneven luminescent signal within standard plates can be caused by
temperature gradients, uneven seeding of cells or edge effects in multiwell
plates.
luminescence.
Note:Instrument settings depend on the manufacturer. An integration time
of 0.25–1 second per well should serve as a guideline.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Part# TB288
Page 6
Printed in USA.
Revised 12/12
ol for Generating an ATP Standard Curve (optional)
It is a good practice to generate a standard curve using the same plate on
which samples are assayed. We recommend ATP disodium salt (Cat.# P1132,
Sigma Cat.# A7699 or GE Healthcare Cat.# 27-1006). The ATP standard curve
should be generated immediately prior to adding the CellTiter-Glo
®
Reagent
because endogenous ATPase enzymes found in sera may reduce ATP levels.
e 1µM ATP in culture medium (100µl of 1µM ATP solution contains
10
–10
moles ATP).
e serial tenfold dilutions of ATP in culture medium (1µM to 10nM;
100µl contains 10
–10
to 10
–12
moles of ATP).
e a multiwell plate with varying concentrations of ATP standard in
100µl medium (25µl for a 384-well plate).
a volume of CellTiter-Glo
®
Reagent equal to the volume of ATP
standard present in each well.
contents for 2 minutes on an orbital shaker.
the plate to incubate at room temperature for 10 minutes to stabilize
the luminescent signal.
luminescence.
ix
ew of the CellTiter-Glo
®
Assay
The assay system uses the properties of a proprietary thermostable luciferase to
enable reaction conditions that generate a stable “glow-type” luminescent
signal while simultaneously inhibiting endogenous enzymes released during
cell lysis (e.g., ATPases). Release of ATPases will interfere with accurate ATP
measurement. Historically, firefly luciferase purified from Photinus pyralis
(LucPpy) has been used in reagents for ATP assays (1,4–7). However, it has
only moderate stability in vitro and is sensitive to its chemical environment,
including factors such as pH and detergents, limiting its usefulness for
developing a robust homogeneous ATP assay. Promega has successfully
developed a stable form of luciferase based on the gene from another firefly,
Photuris pennsylvanica(LucPpe2), using an approach to select characteristics that
improve performance in ATP assays. The unique characteristics of this mutant
(LucPpe2
m
) enabled design of a homogeneous single-reagent-addition approach
to perform ATP assays with cultured cells. Properties of the CellTiter-Glo
®
Reagent overcome the problems caused by factors, such as ATPases, that
interfere with ATP measurement in cell extracts. The reagent is physically
robust and provides a sensitive and stable luminescent output.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 7
ew of the CellTiter-Glo
®
Assay (continued)
Sensitivity and Linearity:The ATP-based detection of cells is more sensitive
than other methods (8–10). In experiments performed by Promega scientists,
the luminescent signal from 50HEK293 cells is greater than three standard
deviations above the background signal from serum-supplemented medium
without cells. There is a linear relationship (r
2
= 0.99) between the luminescent
signal and the number of cells from 0 to 50,000 cells per well in the 96-well
format. The luminescence values in Figure 2 were recorded after 10minutes of
incubation at room temperature to stabilize the luminescent signal as described
in Section3.B. Incubation of the same 96-well plate used in the experiment
shown in Figure 2 for 360minutes at room temperature had little effect on the
relationship between luminescent signal and number of cells (r
2
= 0.99).
Speed:The homogeneous procedure to measure ATP using the CellTiter-Glo
®
Assay is quicker than other ATP assay methods that require multiple steps to
extract ATP and measure luminescence. The CellTiter-Glo
®
Assay also is faster
than other commonly used methods to measure the number of viable cells
(such as MTT, alamarBlue
®
or Calcein-AM) that require prolonged incubation
steps to enable the cells’ metabolic machinery to convert indicator molecules
into a detectable signal.
onal Considerations
Temperature:The intensity and decay rate of the luminescent signal from the
CellTiter-Glo
®
Assay depends on the luciferase reaction rate. Environmental
factors that affect the luciferase reaction rate will change the intensity and
stability of the luminescent signal. Temperature is one factor that affects the
rate of this enzymatic assay and thus the light output. For consistent results,
equilibrate assay plates to a constant temperature before performing the assay.
Transferring eukaryotic cells from 37°C to room temperature has little effect on
ATP content (5). We have demonstrated that removing cultured cells from a
37°C incubator and allowing them to equilibrate to 22°C for 1–2 hours had
little effect on ATP content. For batch-mode processing of multiple assay
plates, take precautions to ensure complete temperature equilibration. Plates
removed from a 37°C incubator and placed in tall stacks at room temperature
will require longer equilibration than plates arranged in a single layer.
Insufficient equilibration may result in a temperature gradient effect between
wells in the center and at the edge of the plates. The temperature gradient
pattern also may depend on the position of the plate in the stack.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Part# TB288
Page 8
Printed in USA.
Revised 12/12
Chemicals:The chemical environment of the luciferase reaction affects the
enzymatic rate and thus luminescence intensity. Differences in luminescence
intensity have been observed using different types of culture media and sera.
The presence of phenol red in culture medium should have little impact on
luminescence output. Assaying 0.1µM ATP in RPMI medium without phenol
red resulted in ~5% increase in luminescence output (in relative light units
[RLU]) compared to assays in RPMI containing the standard concentration of
phenol red, whereas assays in RPMI medium containing twice the normal
concentration of phenol red showed a ~2% decrease in luminescence.
Solvents for the various test compounds may interfere with the luciferase
reaction and thus the light output from the assay. Interference with the
luciferase reaction can be detected by assaying a parallel set of control wells
containing medium without cells. Dimethylsulfoxide (DMSO), commonly used
as a vehicle to solubilize organic chemicals, has been tested at final
concentrations of up to 2% in the assay and only minimally affects light output.
Plate Recommendations:We recommend using standard opaque-walled
multiwell plates suitable for luminescence measurements. Opaque-walled
plates with clear bottoms to allow microscopic visualization of cells also may
be used; however, these plates will have diminished signal intensity and
greater cross talk between wells. Opaque white tape may be used to decrease
luminescence loss and cross talk.
Cellular ATP Content:Different cell types have different amounts of ATP,
and values reported for the ATP level in cells vary considerably (1,4,11–13).
Factors that affect the ATP content of cells may affect the relationship between
cell number and luminescence. Anchorage-dependent cells that undergo
contact inhibition at high densities may show a change in ATP content per cell
at high densities, resulting in a nonlinear relationship between cell number
and luminescence. Factors that affect the cytoplasmic volume or physiology of
cells also will affect ATP content. For example, oxygen depletion is one factor
known to cause a rapid decrease in ATP (1).
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 9
onal Considerations (continued)
Mixing:Optimal assay performance is achieved when the CellTiter-Glo
®
Reagent is mixed completely with the cultured cells. Suspension cell lines (e.g.,
Jurkat cells) generally require less mixing to achieve lysis and extract ATP than
adherent cells (e.g., L929 cells). Tests were done to evaluate the effect of
shaking the plate after adding the CellTiter-Glo
®
Reagent. Suspension cells
cultured in multiwell plates showed only minor differences in light output
whether or not the plates were shaken after adding the CellTiter-Glo
®
Reagent.
Adherent cells are more difficult to lyse and show a substantial difference
between shaken and nonshaken plates.
Several additional parameters related to reagent mixing include the force of
delivery of CellTiter-Glo
®
Reagent, sample volume and dimensions of the well.
All of these factors may affect assay performance. The degree of reagent mixing
required may be affected by the method used to add the CellTiter-Glo
®
Reagent
to the assay plates. Automated pipetting devices using a greater or lesser force
of fluid delivery may affect the degree of subsequent mixing required.
Complete reagent mixing in 96-well plates should be achieved using orbital
plate shaking devices built into many luminometers and the recommended
2-minute shaking time. Special electromagnetic shaking devices that use a
radius smaller than the well diameter may be required to efficiently mix
contents of 384-well plates. The depth of medium and geometry of the
multiwell plates may have an effect on mixing efficiency. We recommend that
you take these factors into consideration when performing the assay and
empirically determine whether a mixing step is necessary for the individual
application.
Luminometers
For highly sensitive luminometric assays, the luminometer model and settings
greatly affect the quality of data obtained. Luminometers from different
manufacturers will vary in sensitivities and dynamic ranges. We recommend
the GloMax
®
products because these instruments do not require gain
adjustments to achieve optimal sensitivity and dynamic range. Additionally,
GloMax
®
instruments are preloaded with Promega protocols for ease of use.
If you are not using a GloMax
®
luminometer, consult the operating manual for
your luminometer to determine the optimal settings. The limits should be
verified on each instrument before analysis of experimental samples. The assay
should be linear in some portion of the detection range of the instrument used.
For an individual luminometer there may be different gain settings. We
recommend that you optimize the gain settings.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Part# TB288
Page 10
Printed in USA.
Revised 12/12
nces
, S.P. et al.(1993) The use of ATP bioluminescence as a measure of cell
proliferation and cytotoxicity. J. Immunol. Methods160, 81–8.
, al.(2004) Multiplexing homogeneous cell-based assays. Cell Notes10, 2–5.
, T., Moravec, R. and Niles, A. (2005) Selecting cell-based assays for drug
discovery screening. Cell Notes13, 16–21.
, L., Grönroos, M. and Nieminen, A.L. (1984) Bioluminescence of cellular ATP:
A new method for evaluating cytotoxic agents in vitro. Med. Biol.62, 338–43.
, A. et al.(1986) Estimation of biomass in growing cell lines by adenosine
triphosphate s Enzymol. 133, 27–42.
, B.U. et al.(1988) Application of an ATP-bioluminescence assay in human tumor
chemosensitivity testing. Gynecol. Oncol.31, 191–204.
dt, al.(1991) Characterization of in vitro chemosensitivity of
perioperative human ovarian malignancies by adenosine triphosphate
chemosensitivity assay. Am. J. Obstet. Gynecol. 165, 245–55.
, R.D. et al.(1995) Comparison of MTT and ATP-based assays for the
measurement of viable cell number. J. Biolumin. Chemilumin.10, 29–34.
, I.A. et al.(1995) Methotrexate chemosensitivity by ATP luminescence in human
leukemia cell lines and in breast cancer primary cultures: Comparison of the TCA-100
assay with a clonogenic assay. AntiCancer Drugs6, 398–404.
a, Y. et al.(1987) The ATP assay is more sensitive than the succinate
dehydrogenase inhibition test for predicting cell viability. Eur. J. Cancer Clin. Oncol.23,
273–6.
y, P.E. (1986) Extraction of adenosine triphosphate from microbial and somatic
cells. Methods Enzymol.133, 14–22.
s, B. et al.(1986) Application of intracellular ATP determination in lymphocytes
for HLA-typing. J. Biolumin. Chemilumin.1, 47–51.
tti, P.E. et al.(1995) Chemosensitivity testing of human tumors using a
microplate adenosine triphosphate luminescence assay: Clinical correlation for
cisplatin resistance of ovarian carcinoma. Cancer Res. 55, 5276–82.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 11
d Products
Cell Proliferation Products
Product
ApoLive-Glo™ Multiplex Assay
ApoTox-Glo™ Triplex Assay
CellTiter-Fluor™ Cell Viability Assay (fluorescent)
CellTiter-Blue
®
Cell Viability Assay (resazurin)
CellTiter 96
®
AQ
ueous
One Solution
Cell Proliferation Assay (MTS, colorimetric)
CellTiter 96
®
AQ
ueous
Non-Radioactive
Cell Proliferation Assay (MTS, colorimetric)
CellTiter 96
®
AQ
ueous
MTS Reagent Powder
CellTiter 96
®
Non-Radioactive
Cell Proliferation Assay (MTT, colorimetric)
Additional sizes available.
Size
10ml
10ml
10ml
20ml
200 assays
1,000 assays
1g
1,000 assays
Cat.#
G6410
G6320
G6080
G8080
G3582
G5421
G1111
G4000
Cytotoxicity Assays
Product
CytoTox-Glo™ Cytotoxicity Assay (luminescent)*
Mitochondrial ToxGlo™ Assay*
MultiTox-Glo Multiplex Cytotoxicity Assay
(luminescent, fluorescent)*
MultiTox-Fluor Multiplex Cytotoxicity Assay
(fluorescent)*
CytoTox-Fluor™ Cytotoxicity Assay (fluorescent)*
CytoTox-ONE™ Homogeneous Membrane
Integrity Assay (LDH, fluorometric)*
CytoTox-ONE™ Homogeneous Membrane
Integrity Assay, HTP
CytoTox 96
®
Non-Radioactive Cytotoxicity Assay
(LDH, colorimetric)*
GSH-Glo™ Glutathione Assay
GSH/GSSG-Glo™ Assay
*Additional sizes available.
Size
10ml
10ml
10ml
10ml
10ml
200–800 assays
1,000–4,000 assays
1,000 assays
10ml
50ml
10ml
50ml
Cat.#
G9290
G8000
G9270
G9200
G9260
G7890
G7892
G1780
V6911
V6912
V6611
V6612
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Part# TB288
Page 12
Printed in USA.
Revised 12/12
Luminometers
Product
GloMax
®
-Multi+ Detection System with Instinct™ Software:
Base Instrument with Shaking
GloMax
®
-Multi+ Detection System with Instinct™ Software:
Base Instrument with Heating and Shaking
GloMax
®
-Multi+ Luminescence Module
Apoptosis Products
Product Size
Caspase-Glo
®
2 Assay*10ml
Caspase-Glo
®
6 Assay*10ml
Caspase-Glo
®
3/7 Assay*2.5ml
Caspase-Glo
®
8 Assay*2.5ml
Caspase-Glo
®
9 Assay*2.5ml
Apo-ONE
®
Homogeneous Caspase-3/7 Assay1ml
DeadEnd™ Fluorometric TUNEL System60 reactions
DeadEnd™ Colorimetric TUNEL System20 reactions
Anti-ACTIVE
®
Caspase-3 pAb50µl
Anti-PARP p85 Fragment pAb50µl
Anti-pS
473
Akt pAb40µl
Caspase Inhibitor Z-VAD-FMK, 20mM50µl
125µl
*Additional sizes available.
Size
1 each
1 each
1 each
Cat.#
E8032
E9032
E8041
Cat.#
G0940
G0970
G8090
G8200
G8210
G7792
G3250
G7360
G7481
G7341
G7441
G7231
G7232
(a)
U.S. Pat. Nos. 6,602,677 and 7,241,584, European Pat. No. 1131441, Japanese Pat. Nos. 4537573 and 4520084 and other patents
pending
(b)
U.S. Pat. No. 7,741,067, Japanese Pat. No. 4485470 and other patents pending.
(c)
U.S. Pat. No. 7,700,310, European Pat. No. 1546374 and other patents pending.
(d)
U.S. Pat. Nos 7,083,911, 7,452,663 and 7,732,128, European Pat. No. 1383914 and Japanese Pat. Nos. 4125600 and 4275715.
(e)
The method of recombinant expression of Coleopteraluciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.
© 2001–2012 Promega Corporation. All Rights Reserved.
Anti-ACTIVE, Apo-ONE, Caspase-Glo, CellTiter 96, CellTiter-Blue, CellTiter-Glo, CytoTox 96 and GloMax are registered
trademarks of Promega Corporation. ApoTox-Glo, ApoLive-Glo, CellTiter-Fluor, CytoTox-Fluor, CytoTox-Glo, CytoTox-ONE,
DeadEnd, GSH-Glo, GSH/GSSG-Glo, Instinct, Mitochondrial ToxGlo and Ultra-Glo are trademarks of Promega Corporation.
alamarBlue is a registered trademark of Trek Diagnostic Ssystems, Inc.
Products may be covered by pending or issued patents or may have certain limitations. Please visit our Web site for more
information.
All prices and specifications are subject to change without prior notice.
Product claims are subject to change. Please contact Promega Technical Services or access the Promega online catalog for the
most up-to-date information on Promega products.
Promega Corporation·2800 Woods Hollow Road ·Madison, WI 53711-5399 USA
Toll Free in USA 800-356-9526·Phone 608-274-4330 ·Fax 608-277-2516 ·
Printed in USA.
Revised 12/12
Part# TB288
Page 13
版权声明:本文标题:CellTiter Glo Luminescent Cell Viability Assay Protocol 内容由网友自发贡献,该文观点仅代表作者本人, 转载请联系作者并注明出处:http://roclinux.cn/p/1735537825a1674162.html, 本站仅提供信息存储空间服务,不拥有所有权,不承担相关法律责任。如发现本站有涉嫌抄袭侵权/违法违规的内容,一经查实,本站将立刻删除。
发表评论